Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REALITY: Reduction of Early Mortality in HIV
NCT01825031Phase 3Completed
- Start
- Jun 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of raltegravir in human immunodeficiency virus infection (HIV). Started Jun 2013; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01825031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01825031.